Examining the Association between Oxidative Stress Markers and the Severity of Symptoms in Individuals with COVID-19 and Healthy Individuals
DOI:
https://doi.org/10.61186/Keywords:
Oxidative stress, COVID-19, Total antioxidant capacity, Total oxidant status, Catalase activityAbstract
Introduction. The association between inflammation and oxidative stress in COVID-19 patients is well documented. The primary objective of the present study was to evaluate the levels of oxidative stress markers in COVID-19 patients compared to the healthy individuals. Methods. In this case-control study, a comprehensive evaluation was conducted on 45 individuals, comprising 30 patients diagnosed with COVID-19 and 15 in a healthy control. COVID-19 patients were divided into two groups: mild and severe, based on clinical severity. In addition to standard laboratory tests like ESR, serum levels of oxidative stress markers were measured, including total protein, total antioxidant capacity, total oxidant status, carbonylated protein content, glutathione reductase enzyme, and catalase activity.Results. ESR levels were significantly elevated in the severe group compared to the mild group. However, no significant differences were observed in the levels of oxidative stress markers between mild and severe COVID-19 patients. Compared to healthy controls, COVID-19 patients exhibited a significant decrease in total protein levels (P < .0001), and significant increases were observed in serum total antioxidant capacity (TAC) (P < .0001) and total oxidant status(TOS) (P = .002).
Conclusion. Oxidative stress markers exhibit a substantial rise in patients with COVID-19, suggesting a potential role in the progression of the disease. Implementing strategies to prevent oxidative stress may offer clinical advantageous in managing COVID-19 patients.
Downloads
References
Lu R, Zhao X, Li J, et al. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet. 2020;395(10224):565-74.
Koo HJ, Lim S, Choe J, Choi SH, Sung H, Do KH. Radiographic and CT features of viral pneumonia. Radiographics. 2018 May;38(3):719-39.
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet. 2020 Feb 15;395(10223):497-506.
Wong KT, Antonio GE, Hui DS, et al. Thin-section CT of severe acute respiratory syndrome: evaluation of 73 patients exposed to or with the disease. Radiology. 2003 Aug;228(2):395-400.
Nanduri J, Yuan G, Kumar GK, Semenza GL, Prabhakar NR. Transcriptional responses to intermittent hypoxia. Respiratory physiology & neurobiology. 2008 Dec 10;164(1-2):277-81.
Cecchini R, Cecchini AL. SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression. Medical Hypotheses. 2020 Oct 1;143:110102.
Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress. Current biology. 2014 May 19;24(10):R453-62.
Kozlov EM, Ivanova E, Grechko AV, Wu WK, Starodubova AV, Orekhov AN. Involvement of oxidative stress and the innate immune system in SARS-CoV-2 infection. Diseases. 2021 Feb 24;9(1):17.
Gjyshi O, Bottero V, Veettil MV, et al. Kaposi's sarcoma-associated herpesvirus induces Nrf2 during de novo infection of endothelial cells to create a microenvironment conducive to infection. PLoS pathogens. 2014 Oct 23;10(10):e1004460.
Fraternale A, Zara C, De Angelis M, et al. Intracellular redox-modulated pathways as targets for effective approaches in the treatment of viral infection. International Journal of Molecular Sciences. 2021 Mar 30;22(7):3603.
Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control measures. Journal of medical virology. 2020 Jun;92(6):568-76.
Laforge M, Elbim C, Frère C, et al. Tissue damage from neutrophil-induced oxidative stress in COVID-19. Nature Reviews Immunology. 2020 Sep;20(9):515-6.
Ntyonga-Pono MP. COVID-19 infection and oxidative stress: an under-explored approach for prevention and treatment?. The Pan African Medical Journal. 2020;35(Suppl 2).
Beltrán-García J, Osca-Verdegal R, Pallardó FV, et al. Oxidative stress and inflammation in COVID-19-associated sepsis: the potential role of anti-oxidant therapy in avoiding disease progression. Antioxidants. 2020 Sep 29;9(10):936.
Yaghoubi N, Youssefi M, Jabbari Azad F, Farzad F, Yavari Z, Zahedi Avval F. Total antioxidant capacity as a marker of severity of COVID‐19 infection: Possible prognostic and therapeutic clinical application. Journal of Medical Virology. 2022 Apr;94(4):1558-65.
Cekerevac I, Turnic TN, Draginic N, et al. Predicting severity and intrahospital mortality in COVID-19: the place and role of oxidative stress. Oxidative medicine and cellular longevity. 2021;2021.
Komaravelli N, Casola A. Respiratory viral infections and subversion of cellular antioxidant defenses. Journal of pharmacogenomics & pharmacoproteomics. 2014 Sep 30;5(4).
Mehri F, Rahbar AH, Ghane ET, Souri B, Esfahani M. Changes in oxidative markers in COVID-19 patients. Archives of medical research. 2021 Nov 1;52(8):843-9.
Halliwell B, Gutteridge JM. Free radicals in biology and medicine. Oxford university press, USA; 2015.
Karkhanei B, Ghane ET, Mehri F. Evaluation of oxidative stress level: total antioxidant capacity, total oxidant status and glutathione activity in patients with COVID-19. New Microbes and New Infections. 2021 Jul 1;42:100897.
Le Bras M, Clement MV, Pervaiz S, Brenner C. Reactive oxygen species and the mitochondrial signaling pathway of cell death. Histology and histopathology. 2005.
Camini FC, da Silva Caetano CC, Almeida LT, de Brito Magalhães CL. Implications of oxidative stress on viral pathogenesis. Archives of virology. 2017 Apr;162:907-17.
Kohen R, Nyska A. Invited review: oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicologic pathology. 2002 Oct;30(6):620-50.
Nohl H, Gille L, Staniek K. Intracellular generation of reactive oxygen species by mitochondria. Biochemical pharmacology. 2005 Mar 1;69(5):719-23.
Berry CE, Hare JM. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. The Journal of physiology. 2004 Mar 16;555(3):589-606.
Aykac K, Ozsurekci Y, Yayla BC, et al. Oxidant and antioxidant balance in patients with COVID‐19. Pediatric pulmonology. 2021 Sep;56(9):2803-10.
Ali AM, Kunugi H. Hypoproteinemia predicts disease severity and mortality in COVID-19: a call for action. Diagnostic Pathology. 2021 Dec;16(1):1-3.
Aryal B, Tillotson J, Ok K, Stoltzfus AT, Michel SL, Rao VA. Metal-induced oxidative stress and human plasma protein oxidation after SARS-CoV-2 infection. Scientific Reports. 2023 Feb 10;13(1):2441.
Amici A, Levine RL, Tsai L, Stadtman ER. Conversion of amino acid residues in proteins and amino acid homopolymers to carbonyl derivatives by metal-catalyzed oxidation reactions. Journal of Biological Chemistry. 1989 Feb 25;264(6):3341-6.
Liu W, COVID LH. 19: Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism ChemRxiv 2020. Preimpresión https://doi org/1026434/chemrxiv. 2020;11938173:v7.
Wenzhong L, Hualan L. COVID-19: captures iron and generates reactive oxygen species to damage the human immune system. Autoimmunity. 2021 May 19;54(4):213-24.
Pham-Huy LA, He H, Pham-Huy C. Free radicals, antioxidants in disease and health. International journal of biomedical science: IJBS. 2008 Jun;4(2):89.
Lage SL, Amaral EP, Hilligan KL, et al. Persistent oxidative stress and inflammasome activation in CD14highCD16− monocytes From COVID-19 patients. Frontiers in immunology. 2022 Jan 14;12:799558.
Cekerevac I, Turnic TN, Draginic N, et al. Predicting severity and intrahospital mortality in COVID-19: the place and role of oxidative stress. Oxidative medicine and cellular longevity. 2021 Mar 26;2021.
